Showing results (1201-1210 of 1,504) with videos related to

Sort By:
Pageof 151
Hepatology (Baltimore, Md.)|January 22, 2011
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathwaysJing Fu, Yao Chen, Jie Cao, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 17, 2019
Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markersZhangjun Cheng, Zhengqing Lei, Anfeng Si, et al.
Journal of Surgical Oncology|April 22, 2016
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinomaAlessandro Vitale, Gaya Spolverato, Fabio Bagante, et al.
Chinese Medical Journal|February 4, 2006
Prognosis of unprotected left main coronary artery stenting and the factors affecting the outcomes in ChineseRun-lin Gao, Bo Xu, Ji-lin Chen, et al.
Cardiovascular Diabetology|December 21, 2006
Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetesLi Jin Pu, Lin Lu, Xue Wei Xu, et al.
Chinese Medical Journal|April 20, 2007
Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical studyQi Zhang, Bo Xu, Yue-jin Yang, et al.
Journal of Surgical Oncology|November 23, 2018
Impact of microvascular invasion on clinical outcomes after curative-intent resection for intrahepatic cholangiocarcinomaLiang-Shuo Hu, Matthew Weiss, Irinel Popescu, et al.
Chinese Medical Journal|December 11, 2007
Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarctionQi Zhang, Jie Shen, Rui-yan Zhang, et al.
Chinese Medical Journal|March 28, 2008
Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stentBo Xu, Qi Zhang, Yue-jin Yang, et al.
Molecular Cancer Therapeutics|January 2, 2015
Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate CancerDavid T Hoang, Lei Gu, Zhiyong Liao, et al.
Pageof 151